Obesity should not be considered a barrier for a patient who needs a shoulder replacement procedure, researchers argued in a ...

“While BMI thresholds have been used to limit access to joint replacement surgery, our findings do not support restricting ...

A poll from the American Gastroenterological Association found that 80% of American adults say gastroenterologists play a ...

Top scientists from have suggested that GLP-1s could have broader effects than just tackling obesity and diabetes.

Discover six obesity deals made so far in 2025, with dealmaking activity in the field being largely dominated by big pharma ...

Eli Lilly & Co. and Novo Nordisk A/S plan to start selling their popular obesity shots to employers through a new approach ...

While heart disease, diabetes and prediabetes are the most common health concerns related to obesity, many other conditions ...

(THE CONVERSATION) The Trump administration is making a significant effort to reduce the cost of weight loss drugs. Its agreement with pharmaceutical giants, announced Nov. 6, 2025, will reduce the ...

Early baby routines in feeding, sleep, and play link to growth. A tool helps families notice habits that may influence ...

Eli Lilly hit $1 trillion in market value on Friday, making it the first drugmaker to enter the exclusive club dominated by ...

With the strength of sales in GLP-1 weight loss drugs Mounjaro and Zepbound, Eli Lilly is now the first pharmaceutical ...

Eli Lilly briefly crossed the $1 trillion market cap threshold, the first drug maker to ever reach that milestone.